The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - A2A Pharmaceuticals, Inc
Leadership - A2A Pharmaceuticals, Inc
Stock and Other Ownership Interests - A2A Pharmaceuticals, Inc
Patents, Royalties, Other Intellectual Property - A2A Pharmaceuticals, Inc
A first-in-human, phase 1 study evaluating oral TACC3 inhibitor, AO-252, in advanced solid tumors.
 
Ecaterina Elena Dumbrava
Consulting or Advisory Role - Bolt Biotherapeutics; Fate Therapeutics; Mersana; PMV Pharma; Summit Therapeutics
Speakers' Bureau - PMV Pharma
Research Funding - A2A Pharmaceuticals (Inst); Aileron Therapeutics (Inst); Amgen (Inst); Aprea Therapeutics (Inst); Astex Pharmaceuticals (Inst); Bayer (Inst); Bellicum Pharmaceuticals (Inst); Boehringer Ingelheim (Inst); Bolt Biotherapeutics (Inst); Compugen (Inst); Dragonfly Therapeutics (Inst); Genentech (Inst); Immunocore (Inst); Immunomedics/Gilead (Inst); Mereo BioPharma 5 (Inst); Mersana (Inst); PMV Pharma (Inst); Poseida (Inst); Rain Therapeutics (Inst); Sanofi (Inst); Seagen (Inst); Soto (Inst); Triumvira Immunologics, Inc (Inst); Volastra Therapeutics (Inst)
Travel, Accommodations, Expenses - Rain Oncology; Triumvira Immunologics, Inc
 
Amber Michelle Kennon
No Relationships to Disclose
 
Wintana A Balema
No Relationships to Disclose
 
Chaemin Lim
Employment - A2A Pharmaceuticals, Inc
Leadership - A2A Pharmaceuticals, Inc
Stock and Other Ownership Interests - A2A Pharmaceuticals, Inc
Patents, Royalties, Other Intellectual Property - A2A Pharmaceuticals, Inc
 
Sridhar Vempati
No Relationships to Disclose
 
Sotirios Stergiopoulos
Employment - A2A Pharmaceuticals, Inc
Leadership - A2A Pharmaceuticals, Inc
Stock and Other Ownership Interests - A2A Pharmaceuticals, Inc
Patents, Royalties, Other Intellectual Property - A2A Pharmaceuticals, Inc
 
Debra L. Richardson
Consulting or Advisory Role - AstraZeneca; Eisai; GlaxoSmithKline; Immunogen; Mersana; ProfoundBio
Research Funding - Aravive (Inst); Arch Oncology (Inst); ArQule (Inst); AstraZeneca (Inst); Celsion (Inst); Clovis Oncology (Inst); Deciphera (Inst); Five Prime Therapeutics (Inst); Fujifilm (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Harpoon therapeutics (Inst); Hookipa Biotech (Inst); Innovent Biologics (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Merck (Inst); Mersana (Inst); Plexxikon (Inst); Roche (Inst); Shattuck Labs (Inst); Syros Pharmaceuticals (Inst); Tesaro (Inst)